Add time:08/11/2019 Source:sciencedirect.com
IntroductionNitroimidazole (azomycin) derivatives labeled with radioisotopes have been developed as cancer imaging and radiotherapeutic agents based on the oncological hypoxic mechanism. By attaching nitroimidazole core with different functional groups, we synthesized new nitroimidazole derivatives and evaluated their potentiality as tumor imaging agents.
We also recommend Trading Suppliers and Manufacturers of 1-FLUORO-3-(2-NITRO-IMIDAZOL-1-YL)-PROPAN-2-OL (cas 13551-89-8). Pls Click Website Link as below: cas 13551-89-8 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View